Cocaine abusers have reduced auditory P50 amplitude and suppression compared to both normal controls and alcoholics

Biological Psychiatry

Volumn 39, Issue 11, 1996, Pages 955-965

  Fein, George ^a,b   Biggins, Christie ^a   Mackay, Shane ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Alcoholism; Auditory ERP; Cocaine P50; Sensory gating

Indexed keywords

COCAINE;

ABSTINENCE; ADULT; ALCOHOLISM; ARTICLE; CLINICAL ARTICLE; CONDITIONING; CONTROLLED STUDY; DRUG ABUSE; EVOKED AUDITORY RESPONSE; HUMAN; MALE; PRIORITY JOURNAL;

EID: 0029949929     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-3223(95)00299-5     Document Type: Article

References (32)

1. Adler LE, Rose G, Freedman R (1986): Neurophysiological studies of sensory gating in rats: Effects of amphetamine, phencyclidine, and haloperidol. Biol Psychiatry 21:787-798.
2. Adler LE, Pang K, Gerhardt G, Rose GM (1988): Modulation of the gating of auditory evoked potentials by norepinephrine: Pharmacological evidence obtained using a selective neurotoxin. Biol Psychiatry 24:179-190.
3. Adler LE, Gerhardt GA, Franks R, Baker N, Nagamoto H, Drebing C, Freedman R (1990): Sensory physiology and catecholamines in schizophrenia and mania. Psychiatry Res 31:297-309.
4. Adler LE, Hoffer LJ, Griffith J, Waldo MC, Freedman R (1992): Normalization by nicotine of deficient auditory sensory gating in the relatives of schizophrenics. Biol Psychiatry 32:607-616.
5. Adler LE, Hoffer LD, Wiser A, Freedman R (1993): Normalization of auditory physiology by cigarette smoking in schizophrenic patients. Am J Psychiatry 150:1856-1861.
6. American Psychiatric Association (1987): Diagnostic and Statistical Manual of Mental Disorders, 3rd ed rev. Washington, DC: American Psychiatric Press.
7. Baker N, Adler LE, Franks RD, Waldo M, Berry S, Nagamoto H, Muckle A, Freedman R (1987): Neurophysiological assessment of sensory gating in psychiatric inpatients: Comparison between schizophrenia and other diagnoses. Biol Psychiatry 22:603-617.
8. Banerjee SP, Sharma VK, Kung-Cheung LS, Chanda SK, Riggi SJ (1979): Cocaine and D-amphetamine induce changes in central beta-adrenoceptor sensitivity: Effects of acute and chronic drug treatment. Brain Res 175:119-130.
9. Bickford-Wimer PC, Nagamoto H, Johnson R, Adler LE, Egan M, Rose GM, Freedman R (1990): Auditory sensory gating in hippocampal neurons: A model system in the rat. Biol Psychiatry 27:183-192.
10. Buchwald JS, Rubinstein EH, Schwafel J, Strandburg RJ (1991): Midlatency auditory evoked responses: Differential effects of a cholinergic agonist and antagonist. Electroencephalogr Clin Neurophysiol 80:303-309.
11. Cacace AT, Satya-Murti S, Wolpaw JR (1990): Human middle-latency auditory evoked potentials: Vertex and temporal components. Electroencephalogr Clin Neurophysiol 77:6-18.
12. Cardenas V, Gerson J, Fein G (1993): The reliability of P50 suppression as measured by the conditioning/testing ratio is vastly improved by dipole modeling. Biol Psychiatry 33:335-344.
13. Dickerson LW, Buchwald JS (1991): Midlatency auditory-evoked responses: Effect of scopolamine in the cat and implications for brain stem cholinergic mechanisms. Exp Neurol 112:229-239.
14. Erwin RJ, Buchwald JS (1987): Midlatency auditory evoked responses in the human and cat model. Electroencephalogr Clin Neurophysiol 40(suppl):461-467.
15. Freedman R, Adler LE, Waldo MC, Pachtman E, Franks RD (1983): Neurophysiological evidence for a defect in inhibitory pathways in schizophrenia: Comparison of medicated and drug-free patients. Biol Psychiatry 18:537-551.
16. Freedman R, Waldo MC, Adler LE, Baker N, Levin D, Deitrich R (1986): Electrophysiological effects of low dose alcohol on human subjects at high altitude. Alcohol Drug Res 6:289-297.
17. Freedman R, Adler LE, Baker N, Waldo M, Mizner G (1987a): Candidate for inherited neurobiological dysfunction in schizophrenia. Somat Cell Mol Genet 13:479-484.
18. Freedman R, Waldo M, Waldo CI III, Wilson JR (1987b): Genetic influences on the effects of alcohol on auditory evoked potentials. Alcohol 4:249-253.
19. Gasser T, Sroka L, Möcks J (1985): The transfer of EOG activity into the EEG for eyes open and closed. Electroencephalogr Clin Neurophysiol 61:181-193.
20. Harrison JB, Woolf NJ, Buchwald JS (1990): Cholinergic neurons of the feline pontomesencephalon: I. Essential role in "Wave A" generation. Brain Res 520:43-54.
21. Hearn WL, Flynn DD, Hime GW, Rose S, Cofino JC, Mantero-Atienza E, Wetli CV, Mash DC (1991): Cocaethylene: A unique cocaine metabolite displays high affinity for the dopamine transporter. J Neurochem 56:698-701.
22. Henry DJ, White FJ (1992): Electrophysiological correlates of psychomotor stimulant-induced sensitization. Ann N Y Acad Sci 654:88-100.
23. Jatlow P, Elsworth JD, Bradberry CW, Winger G, Taylor JR, Russell R, Roth RH (1991): Cocaethylene: A neuropharmacologically active metabolite associated with concurrent cocaine-ethanol ingestion. Life Sci 48:1787-1794.
24. Jerger K, Biggins C, Fein G (1992): P50 suppression is not affected by attentional manipulations. Biol Psychiatry 31: 365-377.
25. Johnson MR, Adler LE (1993): Transient impairment in P50 auditory sensory gating induced by a cold-pressor test. Biol Psychiatry 33:380-387.
26. Karoum F, Suddath RL, Wyatt RJ (1990): Chronic cocaine and rat brain catecholamines: Long-term reduction in hypothalamic and frontal cortex dopamine metabolism. Eur J Pharmacol 186:1-8.
27. McDougle CJ, Black JE, Malison RT, Zimmerman RC, Kosten TR, Heninger GR, Price LH (1994): Noradrenergic dysregulation during discontinuation of cocaine use in addicts. Arch Gen Psychiatry 51:713-719.
28. Miller CL, Bickford PC, Luntz-Leybman V, Adler LE, Gerhardt GA, Freedman R (1992): Phencyclidine and auditory sensory gating in the hippocampus of the rat. Neuropharmacology 31:1041-1048.
29. Nagamoto HT, Adler LE, Waldo MC, Freedman R (1989): Sensory gating in schizophrenics and normal controls: Effects of changing stimulation interval. Biol Psychiatry 25:549-561.
30. Stevens KE, Fuller LL, Rose GM (1991): Dopaminergic and noradrenergic modulation of amphetamine-induced changes in auditory gating. Brain Res 555:91-98.
31. Stevens KE, Meltzer J, Rose GM (1993): Disruption of sensory gating by the α-2 selective noradrenergic antagonist yohimbine. Biol Psychiatry 33:130-132.
32. Straumanis JJ, Shagass C, Roemer RA (1982): Influence of antipsychotic and antidepressant drugs on evoked potential correlates of psychosis. Biol Psychiatry 17:1101-1122.